“Patient-Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis in Real-world Settings: PROAK Study Protocol” (2022) SKIN The Journal of Cutaneous Medicine, 6(2), p. s19. doi:10.25251/skin.6.supp.19.